New antibody drug aims to unleash immune cells on Hard-to-Treat cancers
NCT ID NCT07563829
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This early-phase study tests a new drug called NPX372 in people with advanced solid tumors that have not responded to standard treatments. NPX372 is designed to attach to both cancer cells and immune cells, helping the immune system attack the cancer. The main goals are to check the drug's safety and find the right dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins
Baltimore, Maryland, 21287, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Montefiore
The Bronx, New York, 10461, United States
-
NEXT
Fairfax, Virginia, 22031, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
University of California - San Diego
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.